Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR-Reference-Cited by-同舟云学术

Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR

Published:2014-05-07 Issue:12 Volume:135 Page:2962-2971
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ren Shengxiang¹,Su Chunxia¹,Wang Zhaoye²,Li Jiayu¹,Fan Lihong¹,Li Bing¹,Li Xuefei³,Zhao Cao³,Wu Chunyan⁴,Hou Likun⁴,He Yayi¹,Gao Guanghui¹,Chen Xiaoxia¹,Ren Jiawei⁵,Li Aiwu¹,Xu Guotong⁶,Zhou Xiao⁷,Zhou Caicun¹,Schmid-Bindert Gerald⁸

Affiliation:

1. Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine; Tongji University Medical School Cancer Institute; Shanghai People's Republic of China

2. Department of Cardio-Thoracic Surgery; Zhoushan Hospital of Zhejiang Province; Zhoushan Zhejiang Province People's Republic of China

3. Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital; Tongji University, Tongji University Medical School Cancer Institute; Shanghai People's Republic of China

4. Department of Pathology, Shanghai Pulmonary Hospital; Tongji University School of Medicine; Shanghai People's Republic of China

5. Department of Respiratory Medicine; Shanghai First Hospital Branch; Shanghai People's Republic of China

6. Department of Laboratory Medicine; Tongji University School of Medicine; Shanghai People's Republic of China

7. Department of Thoracic Surgery, Shanghhai Pulmonary Hospital; Tongji University School of Medicine; Shanghai People's Republic of China

8. Department of Surgery; University Medical Center Mannheim, Medical Faculty Mannheim of Heidelberg University; Mannheim Germany

Funder

projects of the Science and Technology Commission of Shanghai Municipality

National Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status;An;PLoS One,2012

2. EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital;Choi;PLoS One,2013

3. Frequency of and variables associated with the EGFR mutation and its subtypes;Tanaka;Int J Cancer,2010

4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

5. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21;Zhu;J Clin Oncol,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial heterogeneity of tumor cells and the tissue microenvironment in oral squamous cell carcinoma;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-12

2. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells;eLife;2022-05-12

3. Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line;Scientific Reports;2022-05-06

4. E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models;Molecular Oncology;2021-12-26

5. Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation;BMC Cancer;2021-07-20